Screening method of endogenous polypeptide and application of screened polypeptide
The invention belongs to the field of small molecule polypeptides, and particularly relates to a screening method of endogenous polypeptides and application of the screened polypeptides. According to the method, whether the separated and purified endogenous polypeptide possibly has a biological acti...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention belongs to the field of small molecule polypeptides, and particularly relates to a screening method of endogenous polypeptides and application of the screened polypeptides. According to the method, whether the separated and purified endogenous polypeptide possibly has a biological activity function or not is screened at a preferentially investigated position, and the polypeptide of which the precursor protein expression level is closely related to the clinical prognosis of the endometrial cancer patient is screened by adopting a bioinformatics analysis tool. The endogenous polypeptide PDAEP-1 derived from endometrial cancer tissues is obtained through screening and is released into a focus microenvironment in a paracrine manner. The PDAEP-1 polypeptide is taken as a target spot, can become a specific target spot for treating endometrial cancer, especially invasion and metastasis patients, and is applied to research and development of novel biological targeting drugs for treating endometrial canc |
---|